Ampio Pharmaceuticals Inc. (AMPE) Fundamentals

Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. Its lead product candidate, Ampion, is in clinical trials and is being developed for the treatment of severe Osteoarthritis of the Knee, an intravenous treatment for COVID-19 patients, and an inhaled treatment for COVID-19 induced respiratory distress.
SHARE INFORMATION
Market Cap$ 5,159,341
Shares Outstanding226,286,867
Float225,840,031
Percent Float99.8%
Short Interest12,005,487.00
Short Percent Float5.3%
Short Interest Ratio1.03
Short Interest Date2022-09-15
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.10
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions230
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months7,126,856
Institutional Holdings Percent25.2%
Institutional Sold Previous 3 Months19,882,572
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months-
Insider Holdings Percent2.0
Insider Sold Previous 3 Months-
Insider Shares Owned4,438,704
TRADING INFO
52 Week High$ 1.79
52 Week Low$ 0.02
52 Week High Change$ -98.58
21 Day Moving Average$ 0.0749
21 Day Extended Moving Average$ 0.073478
50 Day Moving Average$ 0.0944
50 Day Extended Moving Average$ 0.100718
200 Day Moving Average$ 0.292909
200 Day Extended Moving Average$ 0.374527
10 Day Average Volume8,574,484
20 Day Average Volume8,551,520
30 Day Average Volume10,506,811
50 Day Average Volume9,527,763
Alpha0.014574
Beta1.9066
Standard Deviation0.398612
R20.062200
7 Day Price Change$ -0.0414
7 Day Percent Change-64.49%
21 Day Price Change$ -0.0737
21 Day Percent Change-76.37%
30 Day Price Change$ -0.0764
30 Day Percent Change-77.02%
Month to Date Price Change$ -0.0377
Month to Date Percent Change-62.31%
Quarter to Date Price Change$ -0.0377
Quarter to Date Percent Change-62.31%
180 Day Price Change$ -0.4293
180 Day Percent Change-94.96%
200 Day Price Change$ -0.3972
200 Day Percent Change-94.57%
Year to Date Price Change$ -0.5472
Year to Date Percent Change-96.0%

Ampio Pharmaceuticals Inc. (AMPE) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.20
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio4.80
Leverage Ratio1.50
Quick Ratio4.50
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-0.20
Enterprise Value$ -17,478,120
Price to Sales0.00
Price to Free Cash-0.30
PE High Last 5 Years1.70
Price To Book0.20
Price To Cash Flow0.00
PE Low Last 5 Years-5.30
Price to Tangible Book0.20
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-65.12
Return on Equity-86.80
Return on Capital-83.19

Ampio Pharmaceuticals Inc. (AMPE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMoss Adams LLP
CEOMichael A. Martino
Emplyoees18
Last AuditUQ
CIK0001411906
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address373 Inverness Parkway
Suite 200
Englewood, CO 80112
Websitehttps://www.ampiopharma.com
Facsimile+1 720 437-6501
Telephone+1 720 437-6500
Emailinfo@ampiopharma.com


Your Recent History
AMEX
AMPE
Ampio Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.